News & Press Releases
NEWS
Presentation of Saturn at NY Valves – June, 2025
At New York Valves on Friday, June 27th, Dr. Torsten Vahl from Columbia University Irving Medical Center gave an overview of the CASSINI-EU EFS study on Saturn Trans-septal TMVR System, focusing on the one year follow up of the first Trans-septal patient. The...
Presentation of Saturn at TCT – October 2024
At TCT2024 on Tuesday, October 29, Dr. Torsten Vahl from Columbia University Irving Medical Center reviewed the first 3 patients in CASSINI-EU EFS study on Saturn Trans-septal TMVR System in the presentation ‘Novel TMVR Systems on the Launchpad’ during ‘TCT Innovation...
SATURN Transapical Early Feasibility in Annals of Thoracic Surgery Short Reports
Annals of Thoracic Surgery Short Reports just published Early Feasibility Study with the SATURN Transapical Mitral Valve Replacement Device, available at https://doi.org/10.1016/j.atssr.2024.06.011. Deep gratitude and congratulation to the authors: Prof. Kęstutis...
Presentation of Saturn and First-in-Human TS at NY Valves – June 2024
Our technology and first trans-septal implant have been presented at NY Valves 2024 held on June 5-7 in Jacob K. Javits Convention Center, New York. Specifically, Dr. Lauren S. Ranard, MD from Columbia University Irving Medical Center, held a presentation named...
Saturn TMVR System in Eurointervention
Eurointervention, the official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), published preclinical data on our novel, investigational Saturn TMVR device in the article Procedural performance and healing response...
PRESS RELEASES
Transcatheter Mitral Valve Replacement Company InnovHeart Closes Series B Financing of €20 Million
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, announced today the closing of a €20 million round of equity financing. Founded in 2015 by Giovanni Righini, a 30-year veteran of...
InnovHeart Elects Keith D. Dawkins MD as Chairman of the Board
Dr. Dawkins is transitioning from his position as a member of the InnovHeart Board which he joined in May of this year. Dr. Dawkins has more than 35 years experience as both a practicing phys ician and an executive within the medical device industry. He currently also...
InnovHeart Appoints Keith D. Dawkins, M.D., as Board Member
InnovHeart s.r.l., a developer of novel transcatheter mitral valve replacement (TMVR) systems for the treatment of mitral valve disease, announces the appointment of veteran medical device executive Keith D. Dawkins, M.D., to a newly created position on its Board of Directors.